Skip to content
OpenCapital
Get started

Annovis Bio ANVS Q3 2025 earnings

Reported November 12, 2025 · Before market open

Diluted EPS-$0.37Miss by $0.01
EPS estimate-$0.36

Next report

Aug 11, 2026 (In 4 weeks)
EPS estimate-$0.44

Versus estimates

Diluted EPS

Q1 2026-$0.63Miss by $0.24Q4 2025-$0.39Miss by $0.08
Q3 2025-$0.37Miss by $0.01
Q2 2025-$0.32Beat by $0.04Q1 2025-$0.32Beat by $0.15Q4 2024-$0.43Miss by $0.05

Ask the moment Annovis Bio reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Annovis Bio report Q3 2025 earnings?
Annovis Bio (ANVS) reported Q3 2025 earnings on November 12, 2025 before market open.
What were Annovis Bio's Q3 2025 revenue and EPS?
Annovis Bio reported diluted EPS of $-0.37 for Q3 2025.
Did Annovis Bio beat estimates in Q3 2025?
EPS missed the consensus estimate of $-0.36 by $0.01.
How did Annovis Bio's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS grew 61.9% from $-0.97.
Where can I find Annovis Bio's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001104659-25-110548) and the 10-Q periodic report (0001104659-25-110393) directly on SEC EDGAR. The filing index links above go to sec.gov.